Skip to main content

Paul L Crispen, MD : Research

Cancer Specialist (Oncologist), Urologist

Rated 4.9 out of 5 stars
Photo of Paul L Crispen

Research at a glance

Top areas of exploration

  • Kidney Neoplasms , 39 publications
  • Carcinoma, Renal Cell , 28 publications
  • Nephrectomy , 20 publications
  • Prostatic Neoplasms , 19 publications

Research activity

100 publications

4,874 citations

Why is this important?

Active clinical trials

My publications

100 publications

2026

Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification.

Urology

PubMed Publisher's site

2026

Patient awareness and perspectives regarding the value of focal therapy for localized prostate cancer: A cross-sectional study.

Urologic oncology

PubMed Publisher's site

2026

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

PubMed Publisher's site

2025

TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial.

The Lancet. Oncology

PubMed Publisher's site

2024

Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.

Urologic oncology

PubMed Publisher's site